In NB, the proto-oncogene MYCN serves as a key driver of tumorigenesis by regulating the expression of multiple proteins involved in lipid metabolism, including FASN, stearoyl-CoA desaturase 1 (SCD1), and FATP2. This evidence concerns the gene MYCN and neuroblastoma.